Angiographic predictors of femoral access site complications: Implication for planned percutaneous coronary intervention

Catheterization and Cardiovascular Interventions

Volumn 65, Issue 2, 2005, Pages 196-202

  Sherev, Dimitri A ^a   Shaw, Richard E ^a   Brent, Bruce N ^a,b  

^a CALIFORNIA PACIFIC MEDICAL CENTER   (United States)

^b NONE   (United States)

Author keywords

Anatomy; Coronary angioplasty; Femoral artery; Hematoma; Percutaneous coronary intervention; Pseudoaneurysm; Retroperitoneal bleeding

Indexed keywords

ADULT; AGED; ARTERIOTOMY; ARTICLE; CLINICAL ARTICLE; COHORT ANALYSIS; FEMALE; FEMORAL ANGIOGRAPHY; FEMORAL ARTERY; HEART CATHETERIZATION; HUMAN; INFERIOR EPIGASTRIC ARTERY; INTERVENTIONAL CARDIOVASCULAR PROCEDURE; MALE; OUTCOMES RESEARCH; PERCUTANEOUS CORONARY INTERVENTION; PROSPECTIVE STUDY; RETROPERITONEAL HEMORRHAGE; RISK ASSESSMENT; RISK FACTOR; VASCULAR ACCESS; VASCULAR DISEASE;

AGED; AGED, 80 AND OVER; ANGIOGRAPHY; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; FEMALE; FEMORAL ARTERY; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; POSTOPERATIVE HEMORRHAGE; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RETROPERITONEAL SPACE; RETROSPECTIVE STUDIES;

EID: 20344401336     PISSN: 15221946     EISSN: None     Source Type: Journal    
DOI: 10.1002/ccd.20354     Document Type: Article

References (36)

1. Chandrasekar B, Doucet S, Bilodeau L, et al. Complications of cardiac catheterization in the current era: a single-center experience. Catheter Cardiovasc Interv 2001;52:289-295.
2. Noto TJ, Johnson LW, Krone R, et al. Cardiac catheterization 1990: a report of the registry of the Society for Cardiac Angiography and Interventions. Cathet Cardiovasc Diagn 1991;24:75.
3. Pompa JJ, Satler LF, Pichard AD, et al. Vascular complications after balloon and new device angioplasty. Circulation 1993;88:1569-1578.
4. Muller DW, Shamir KJ, Ellis SG, Topol EJ. Periferal vascular complications after conventional and complex percutaneous coronary interventional procedures. Am J Cardiol 1992;69:63-68.
5. Blackenship JC, Hellkamp AS, Aquirre FV, Denko SL, Topol EJ, Califf RM. Vascular access site complications after percutaneous coronary intervention with abciximab in the evaluation of c7E3 for the prevention of ichemic complications (EPIC) trial. Am J Cardiol 1998;81:36-40.
6. Steinhubl SR, Berger PB, Mann JT III, et al. Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: the CREDO trial. JAMA 2003;288:2411-2420.
7. Lincoff MA, Bittl JA, Harrington RA, et al. Bivalirudin and provisional glycoprotein IIb/IIIa blockade compared with heparin and planned glycoprotein IIb/IIa blocade during percutaneous coronary intervention: Replace-2 trial. JAMA 2003;289:853-863.
8. EPIC investigators. Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty. N Engl J Med 1994;330:956-961.
9. Van De Werf F, Armstrong PW, Granger C, Wallentin L, et al. Efficacy and safety of tencteplase in combination with enoxaparin, abxicimab, or unfractinated heparin: the ASSENT-3 randomized trial in acute myocardial infarction. Lancet 2001;358:605-613.
10. Levine GN, Kern MJ, Berger PB, et al. Management of patients undergoing percutaneous coronary interventions. Ann Intern Med 2003;139:123-136.
11. Jackson JE, Allison DJ, Hemingway AP. Principles, techniques and complications of angiography. In: Grainger RG, Allison D, Adams A, Dixon A, editors. Grainger and Allison's diagnostic radiology: a textbook of medical imaging, 4th ed. New York: Churchill Livingston; 2001. p 149-159.
12. Mandak JS, Blankenship JC, Gardner LH, et al. Modifiable risk factors for vascular access site complications in the IMPACT II trial of angioplasty with versus without eptifibatide. J Am Coll Cardiol 1998;31:1518-1524.
13. Omoigui NA, Califf RM, Pieper K, et al. Peripheral vascular complications in the Coronary Angioplasty Versus Excisional Atherectomy Trial (CAVEAT-I). J Am Coll Cardiol 1995;26:922-930.
14. Waksman R, King SB III, Douglas JS, et al. Predictors of groin complications after balloon and new-device coronary intervention. Am J Cardiol 1995;75:886-889.
15. White CJ. Management of access site complications: CathSAP II-catheterization and interventional cardiology self-assessment program. Washington, DC: American College of Cardiology; 2001. p 1-20.
16. Safian RD, Freed MS. Coronary intervention preparation, equipment and technique. In: Safian RD, Freed MS, editors. The manual of interventional cardiology, 3rd ed. Royal Oak, IL: Physicians' Press; 2001. p 1-32.
17. Baim DS, Grossman W. Complications of cardiac catheterization. In: Baim DS, Grossman W, editors. Grossman's cardiac catheterization, angiography, and intervention, 6th ed. Philadelphia: Lippincott Williams and Wilkins; 2000. p 35-65.
18. Rapaport S, Sniderman KW, Morse SS, Proto MH, Ross GR. Pseudoaneurysm: a complication of faulty technique in femoral arterial puncture. Radiology 1985;154:529-530.
19. Kiemeneij F, Laarman GJ, Odekerken D, Slagboom T, van der WR. A randomized comparison of percutaneous transluminal coronary angioplasty by the radial, brachial and femoral approaches: the access study. J Am Coll Cardiol 1997;29:1269-1275.
20. Kent KC, Moscucci M, Mansour KA, et al. Retroperitoneal hematoma after cardiac catheterization: prevalence, risk factors, and optimal management. J Vasc Surg 1994;20:905-910.
21. Aguirre FV, Topol EJ, Ferguson JJ, et al. Bleeding complications with the chimeric antibody to platelet glycoprotein IIb/IIIa integrin in patients undergoing percutaneous coronary intervention: EPIC investigators. Circulation 1995;91:2882-2890.
22. Ellis SG, Roubin GS, Wilentz J, Douglas JS Jr, King SB III. Effect of 18- to 24-hour heparin administration for prevention of restenosis after uncomplicated coronary angioplasty. Am Heart J 1989;117:777-782.
23. Garachemani AR, Kaufmann U, Fleisch M, Meier B. Prolonged heparin after uncomplicated coronary interventions: a prospective, randomized trial. Am Heart J 1998;136:352-356.
24. Johnson LW, Esente P, Giambartolomei A, et al. Peripheral vascular complications of coronary angioplasty by the femoral and brachial techniques. Cathet Cardiovasc Diagn 1994;31:165-172.
25. Kresowik TF, Khoury MD, Miller BV, et al. A prospective study of the incidence and natural, history of femoral vascular complications after percutaneous transluminal coronary angioplasty. J Vasc Surg 1991;13:328-333.
26. Metz D, Meyer P, Touati C, et al. Comparison of 6F with 7F and 8F guiding catheters for elective coronary angioplasty: results of a prospective, multicenter, randomized trial. Am Heart J 1997;134:131-137.
27. Moscucci M, Mansour KA, Kent KC, et al. Peripheral vascular complications of directional coronary atherectomy and stenting: predictors, management, and outcome. Am J Cardiol 1994;74:448-453.
28. Muller DW, Shamir KJ, Ellis SG, Topol EJ. Peripheral vascular complications after conventional and complex percutaneous coronary interventional procedures. Am J Cardiol 1992;69:63-68.
29. Oweida SW, Roubin GS, Smith RB III, Salam AA. Postcatheterization vascular complications associated with percutaneous transluminal coronary angioplasty. J Vasc Surg 1990;12:310-315.
30. Wyman RM, Safian RD, Portway V, Skillman JJ, McKay RG, Baim DS. Current complications of diagnostic and therapeutic cardiac catheterization. J Am Coll Cardiol 1988;12:1400-1406.
31. Slater J, Selzer F, Feit F, et al. The impact of access site hematoma with transfusion in patients undergoing percutaneous coronary intervention: a report from the NHLBI dynamic registry. Am J Cardiol 2003;92(suppl):19.
32. Sittig KM, Rohr MS, McDonald JC. Abdominal wall, umbilicus, peritonium, mesenteries, omentum, and retroperitonium. In: Townsend CM, Buachamp RO, Evers BM, Mattay KL, editors. Sabistan Textbook of surgery. 16th ed. Philadelphia: W.B. Saunders; 2001. p 769-773.
33. Bannister LH, Berry MM, Collins P, et al. Common iliac arteries. In: Bannister LH, Berry MM, Collins P, et al., editors. Gray's anatomy: the anatomic basis of medicine and surgery, 38th ed. New York: Pearson Professional; 1995. p 1558-1568.
34. Chamberlin JR, Lardi AB, McKeever LS, et al. Use of vascular sealing devices (Vasoseal and Perclose) versus assisted manual compression (Femostop) in trnascatheter coronary interventions requiring abciximab (ReoPro). Catheter Cardiovasc Interv 1999;47:143-148.
35. Spokojny AM, Sanborn TA. Management of arterial puncture site. J Interv Cardiol 1994;7:187-193.
36. Schnyder G, Sawhney N, Whisenant B, Tsimikas S, Turi ZG. Common femoral artery anatomy is influenced by demographics and comorbidities: implications for cardiac and peripheral invasive studies. Catheter Cardiovasc Interv 2001;53:289-295.